You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Devices & Consumables

Global Veterinary Autogenous Vaccines Market Research Report 2021, Competitive Analysis, Industry Growth Trends And Forecast 2027

The autogenous vaccine is a vaccine prepared from cultures of microorganisms obtained from an individual and then used to immunize that same individual against further spread and progress of the same microorganisms.
The global Veterinary Autogenous Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
In terms of production side, this report researches the Veterinary Autogenous Vaccines production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Veterinary Autogenous Vaccines by regions (countries) and by Application.
The global Veterinary Autogenous Vaccines market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Veterinary Autogenous Vaccines market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Veterinary Autogenous Vaccines markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Veterinary Autogenous Vaccines market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Veterinary Autogenous Vaccines market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Veterinary Autogenous Vaccines market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Veterinary Autogenous Vaccines market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Veterinary Autogenous Vaccines market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Veterinary Autogenous Vaccines market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Veterinary Autogenous Vaccines market by each application segment for the same period.
This report includes the following manufacturers:
ZOETIS
Ceva Biovac
Boehringer Ingelheim
Gallant Custom Laboratories
UVAXX
Bimeda
Dyntec
Elanco Animal Health
Vaxxinova
Hygieia Biological Laboratories
Deltamune Animal Health
Genova Labs
Newport Laboratories
Epitopix
LOHMANN TIERZUCHT
Addison Biological Laboratory
Phibro Animal Health Corporation
Market Segment by Type
Pet Vaccine
Livestock Vaccine
Market Segment by Application
Research Facility
Pet Clinic
Ranches
Others
Research Methodology
To compile the detailed study of the global Veterinary Autogenous Vaccines market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Veterinary Autogenous Vaccines market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Veterinary Autogenous Vaccines market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.

1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Veterinary Autogenous Vaccines Market Size Growth Rate by Type
1.2.2 Pet Vaccine
1.2.3 Livestock Vaccine
1.3 Market Segment by Application
1.3.1 Global Veterinary Autogenous Vaccines Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Research Facility
1.3.3 Pet Clinic
1.3.4 Ranches
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Market Perspective
2.1 Global Veterinary Autogenous Vaccines Market Size (2016-2027)
2.1.1 Global Veterinary Autogenous Vaccines Revenue (2016-2027)
2.1.2 Global Veterinary Autogenous Vaccines Sales (2016-2027)
2.2 Global Veterinary Autogenous Vaccines Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Veterinary Autogenous Vaccines Sales by Regions (2016-2021)
2.2.2 Global Veterinary Autogenous Vaccines Revenue by Regions (2016-2021)
2.3 Global Veterinary Autogenous Vaccines Market Size Forecast by Region
2.3.1 Global Veterinary Autogenous Vaccines Sales Forecast by Region (2022-2027)
2.3.2 Global Veterinary Autogenous Vaccines Revenue Forecast by Region (2022-2027)
2.4 Global Top Veterinary Autogenous Vaccines Regions (Countries) Ranking by Market Size
2.5 Veterinary Autogenous Vaccines Industry Trends
2.5.1 Veterinary Autogenous Vaccines Market Trends
2.5.2 Veterinary Autogenous Vaccines Market Drivers
2.5.3 Veterinary Autogenous Vaccines Market Challenges
2.5.4 Veterinary Autogenous Vaccines Market Restraints

3 Competitive Landscape by Manufacturers
3.1 Global Top Veterinary Autogenous Vaccines Manufacturers by Sales (2016-2021)
3.1.1 Global Veterinary Autogenous Vaccines Sales by Manufacturers (2016-2021)
3.1.2 Global Veterinary Autogenous Vaccines Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Veterinary Autogenous Vaccines Sales in 2020
3.2 Global Top Manufacturers Veterinary Autogenous Vaccines by Revenue
3.2.1 Global Veterinary Autogenous Vaccines Revenue by Manufacturers (2016-2021)
3.2.2 Top Veterinary Autogenous Vaccines Manufacturers Covered: Ranking by Revenue
3.2.3 Global Veterinary Autogenous Vaccines Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Veterinary Autogenous Vaccines Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Veterinary Autogenous Vaccines as of 2020)
3.4 Global Veterinary Autogenous Vaccines Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Veterinary Autogenous Vaccines Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Veterinary Autogenous Vaccines Market
3.7 Key Manufacturers Veterinary Autogenous Vaccines Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Global Veterinary Autogenous Vaccines Market Size by Type
4.1 Global Veterinary Autogenous Vaccines Historic Market Review by Type (2016-2021)
4.1.1 Global Veterinary Autogenous Vaccines Sales Market Share by Type (2016-2021)
4.1.2 Global Veterinary Autogenous Vaccines Revenue Market Share by Type (2016-2021)
4.1.3 Veterinary Autogenous Vaccines Price by Type (2016-2021)
4.2 Global Veterinary Autogenous Vaccines Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Veterinary Autogenous Vaccines Sales Forecast by Type (2022-2027)
4.2.2 Global Veterinary Autogenous Vaccines Revenue Forecast by Type (2022-2027)
4.2.3 Veterinary Autogenous Vaccines Price Forecast by Type (2022-2027)

5 Global Veterinary Autogenous Vaccines Market Size by Application
5.1 Global Veterinary Autogenous Vaccines Historic Market Review by Application (2016-2021)
5.1.1 Global Veterinary Autogenous Vaccines Sales Market Share by Application (2016-2021)
5.1.2 Global Veterinary Autogenous Vaccines Revenue Market Share by Application (2016-2021)
5.1.3 Veterinary Autogenous Vaccines Price by Application (2016-2021)
5.2 Global Veterinary Autogenous Vaccines Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Veterinary Autogenous Vaccines Sales Forecast by Application (2022-2027)
5.2.2 Global Veterinary Autogenous Vaccines Revenue Forecast by Application (2022-2027)
5.2.3 Veterinary Autogenous Vaccines Price Forecast by Application (2022-2027)

6 North America
6.1 North America Veterinary Autogenous Vaccines Sales Breakdown by Company
6.1.1 North America Veterinary Autogenous Vaccines Sales by Company (2016-2027)
6.1.2 North America Veterinary Autogenous Vaccines Revenue by Company (2016-2027)
6.2 North America Veterinary Autogenous Vaccines Market Size by Type (2016-2027)
6.2.1 North America Veterinary Autogenous Vaccines Sales by Type (2016-2027)
6.2.2 North America Veterinary Autogenous Vaccines Revenue by Type (2016-2027)
6.3 North America Veterinary Autogenous Vaccines Market Size by Application (2016-2027)
6.3.1 North America Veterinary Autogenous Vaccines Sales by Application (2016-2027)
6.3.2 North America Veterinary Autogenous Vaccines Revenue by Application (2016-2027)
6.4 North America Veterinary Autogenous Vaccines Market Size by Country
6.4.1 North America Veterinary Autogenous Vaccines Sales by Country (2016-2027)
6.4.2 North America Veterinary Autogenous Vaccines Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Veterinary Autogenous Vaccines Sales Breakdown by Company
7.1.1 Europe Veterinary Autogenous Vaccines Sales by Company (2016-2027)
7.1.2 Europe Veterinary Autogenous Vaccines Revenue by Company (2016-2027)
7.2 Europe Veterinary Autogenous Vaccines Market Size by Type (2016-2027)
7.2.1 Europe Veterinary Autogenous Vaccines Sales by Type (2016-2027)
7.2.2 Europe Veterinary Autogenous Vaccines Revenue by Type (2016-2027)
7.3 Europe Veterinary Autogenous Vaccines Market Size by Application (2016-2027)
7.3.1 Europe Veterinary Autogenous Vaccines Sales by Application (2016-2027)
7.3.2 Europe Veterinary Autogenous Vaccines Revenue by Application (2016-2027)
7.4 Europe Veterinary Autogenous Vaccines Market Size by Country
7.4.1 Europe Veterinary Autogenous Vaccines Sales by Country (2016-2027)
7.4.2 Europe Veterinary Autogenous Vaccines Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Veterinary Autogenous Vaccines Sales Breakdown by Company
8.1.1 Asia Pacific Veterinary Autogenous Vaccines Sales by Company (2016-2027)
8.1.2 Asia Pacific Veterinary Autogenous Vaccines Revenue by Company (2016-2027)
8.2 Asia Pacific Veterinary Autogenous Vaccines Market Size by Type (2016-2027)
8.2.1 Asia Pacific Veterinary Autogenous Vaccines Sales by Type (2016-2027)
8.2.2 Asia Pacific Veterinary Autogenous Vaccines Revenue by Type (2016-2027)
8.3 Asia Pacific Veterinary Autogenous Vaccines Market Size by Application (2016-2027)
8.3.1 Asia Pacific Veterinary Autogenous Vaccines Sales by Application (2016-2027)
8.3.2 Asia Pacific Veterinary Autogenous Vaccines Revenue by Application (2016-2027)
8.4 Asia Pacific Veterinary Autogenous Vaccines Market Size by Regions
8.4.1 Asia Pacific Veterinary Autogenous Vaccines Sales by Regions
8.4.2 Asia Pacific Veterinary Autogenous Vaccines Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Veterinary Autogenous Vaccines Sales Breakdown by Company
9.1.1 Latin America Veterinary Autogenous Vaccines Sales by Company (2016-2027)
9.1.2 Latin America Veterinary Autogenous Vaccines Revenue by Company (2016-2027)
9.2 Latin America Veterinary Autogenous Vaccines Market Size by Type (2016-2027)
9.2.1 Latin America Veterinary Autogenous Vaccines Sales by Type (2016-2027)
9.2.2 Latin America Veterinary Autogenous Vaccines Revenue by Type (2016-2027)
9.3 Latin America Veterinary Autogenous Vaccines Market Size by Application (2016-2027)
9.3.1 Latin America Veterinary Autogenous Vaccines Sales by Application (2016-2027)
9.3.2 Latin America Veterinary Autogenous Vaccines Revenue by Application (2016-2027)
9.4 Latin America Veterinary Autogenous Vaccines Market Size by Country
9.4.1 Latin America Veterinary Autogenous Vaccines Sales by Country (2016-2027)
9.4.2 Latin America Veterinary Autogenous Vaccines Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Veterinary Autogenous Vaccines Sales Breakdown by Company
10.1.1 Middle East and Africa Veterinary Autogenous Vaccines Sales by Company (2016-2027)
10.1.2 Middle East and Africa Veterinary Autogenous Vaccines Revenue by Company (2016-2027)
10.2 Middle East and Africa Veterinary Autogenous Vaccines Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Veterinary Autogenous Vaccines Sales by Type (2016-2027)
10.2.2 Middle East and Africa Veterinary Autogenous Vaccines Revenue by Type (2016-2027)
10.3 Middle East and Africa Veterinary Autogenous Vaccines Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Veterinary Autogenous Vaccines Sales by Application (2016-2027)
10.3.2 Middle East and Africa Veterinary Autogenous Vaccines Revenue by Application (2016-2027)
10.4 Middle East and Africa Veterinary Autogenous Vaccines Market Size by Country
10.4.1 Middle East and Africa Veterinary Autogenous Vaccines Sales by Country (2016-2027)
10.4.2 Middle East and Africa Veterinary Autogenous Vaccines Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Company Profiles
11.1 ZOETIS
11.1.1 ZOETIS Corporation Information
11.1.2 ZOETIS Overview
11.1.3 ZOETIS Veterinary Autogenous Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 ZOETIS Veterinary Autogenous Vaccines Products and Services
11.1.5 ZOETIS Veterinary Autogenous Vaccines SWOT Analysis
11.1.6 ZOETIS Recent Developments
11.2 Ceva Biovac
11.2.1 Ceva Biovac Corporation Information
11.2.2 Ceva Biovac Overview
11.2.3 Ceva Biovac Veterinary Autogenous Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 Ceva Biovac Veterinary Autogenous Vaccines Products and Services
11.2.5 Ceva Biovac Veterinary Autogenous Vaccines SWOT Analysis
11.2.6 Ceva Biovac Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Corporation Information
11.3.2 Boehringer Ingelheim Overview
11.3.3 Boehringer Ingelheim Veterinary Autogenous Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 Boehringer Ingelheim Veterinary Autogenous Vaccines Products and Services
11.3.5 Boehringer Ingelheim Veterinary Autogenous Vaccines SWOT Analysis
11.3.6 Boehringer Ingelheim Recent Developments
11.4 Gallant Custom Laboratories
11.4.1 Gallant Custom Laboratories Corporation Information
11.4.2 Gallant Custom Laboratories Overview
11.4.3 Gallant Custom Laboratories Veterinary Autogenous Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 Gallant Custom Laboratories Veterinary Autogenous Vaccines Products and Services
11.4.5 Gallant Custom Laboratories Veterinary Autogenous Vaccines SWOT Analysis
11.4.6 Gallant Custom Laboratories Recent Developments
11.5 UVAXX
11.5.1 UVAXX Corporation Information
11.5.2 UVAXX Overview
11.5.3 UVAXX Veterinary Autogenous Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 UVAXX Veterinary Autogenous Vaccines Products and Services
11.5.5 UVAXX Veterinary Autogenous Vaccines SWOT Analysis
11.5.6 UVAXX Recent Developments
11.6 Bimeda
11.6.1 Bimeda Corporation Information
11.6.2 Bimeda Overview
11.6.3 Bimeda Veterinary Autogenous Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 Bimeda Veterinary Autogenous Vaccines Products and Services
11.6.5 Bimeda Veterinary Autogenous Vaccines SWOT Analysis
11.6.6 Bimeda Recent Developments
11.7 Dyntec
11.7.1 Dyntec Corporation Information
11.7.2 Dyntec Overview
11.7.3 Dyntec Veterinary Autogenous Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 Dyntec Veterinary Autogenous Vaccines Products and Services
11.7.5 Dyntec Veterinary Autogenous Vaccines SWOT Analysis
11.7.6 Dyntec Recent Developments
11.8 Elanco Animal Health
11.8.1 Elanco Animal Health Corporation Information
11.8.2 Elanco Animal Health Overview
11.8.3 Elanco Animal Health Veterinary Autogenous Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.8.4 Elanco Animal Health Veterinary Autogenous Vaccines Products and Services
11.8.5 Elanco Animal Health Veterinary Autogenous Vaccines SWOT Analysis
11.8.6 Elanco Animal Health Recent Developments
11.9 Vaxxinova
11.9.1 Vaxxinova Corporation Information
11.9.2 Vaxxinova Overview
11.9.3 Vaxxinova Veterinary Autogenous Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.9.4 Vaxxinova Veterinary Autogenous Vaccines Products and Services
11.9.5 Vaxxinova Veterinary Autogenous Vaccines SWOT Analysis
11.9.6 Vaxxinova Recent Developments
11.10 Hygieia Biological Laboratories
11.10.1 Hygieia Biological Laboratories Corporation Information
11.10.2 Hygieia Biological Laboratories Overview
11.10.3 Hygieia Biological Laboratories Veterinary Autogenous Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.10.4 Hygieia Biological Laboratories Veterinary Autogenous Vaccines Products and Services
11.10.5 Hygieia Biological Laboratories Veterinary Autogenous Vaccines SWOT Analysis
11.10.6 Hygieia Biological Laboratories Recent Developments
11.11 Deltamune Animal Health
11.11.1 Deltamune Animal Health Corporation Information
11.11.2 Deltamune Animal Health Overview
11.11.3 Deltamune Animal Health Veterinary Autogenous Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.11.4 Deltamune Animal Health Veterinary Autogenous Vaccines Products and Services
11.11.5 Deltamune Animal Health Recent Developments
11.12 Genova Labs
11.12.1 Genova Labs Corporation Information
11.12.2 Genova Labs Overview
11.12.3 Genova Labs Veterinary Autogenous Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.12.4 Genova Labs Veterinary Autogenous Vaccines Products and Services
11.12.5 Genova Labs Recent Developments
11.13 Newport Laboratories
11.13.1 Newport Laboratories Corporation Information
11.13.2 Newport Laboratories Overview
11.13.3 Newport Laboratories Veterinary Autogenous Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.13.4 Newport Laboratories Veterinary Autogenous Vaccines Products and Services
11.13.5 Newport Laboratories Recent Developments
11.14 Epitopix
11.14.1 Epitopix Corporation Information
11.14.2 Epitopix Overview
11.14.3 Epitopix Veterinary Autogenous Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.14.4 Epitopix Veterinary Autogenous Vaccines Products and Services
11.14.5 Epitopix Recent Developments
11.15 LOHMANN TIERZUCHT
11.15.1 LOHMANN TIERZUCHT Corporation Information
11.15.2 LOHMANN TIERZUCHT Overview
11.15.3 LOHMANN TIERZUCHT Veterinary Autogenous Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.15.4 LOHMANN TIERZUCHT Veterinary Autogenous Vaccines Products and Services
11.15.5 LOHMANN TIERZUCHT Recent Developments
11.16 Addison Biological Laboratory
11.16.1 Addison Biological Laboratory Corporation Information
11.16.2 Addison Biological Laboratory Overview
11.16.3 Addison Biological Laboratory Veterinary Autogenous Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.16.4 Addison Biological Laboratory Veterinary Autogenous Vaccines Products and Services
11.16.5 Addison Biological Laboratory Recent Developments
11.17 Phibro Animal Health Corporation
11.17.1 Phibro Animal Health Corporation Corporation Information
11.17.2 Phibro Animal Health Corporation Overview
11.17.3 Phibro Animal Health Corporation Veterinary Autogenous Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.17.4 Phibro Animal Health Corporation Veterinary Autogenous Vaccines Products and Services
11.17.5 Phibro Animal Health Corporation Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Veterinary Autogenous Vaccines Value Chain Analysis
12.2 Veterinary Autogenous Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Veterinary Autogenous Vaccines Production Mode & Process
12.4 Veterinary Autogenous Vaccines Sales and Marketing
12.4.1 Veterinary Autogenous Vaccines Sales Channels
12.4.2 Veterinary Autogenous Vaccines Distributors
12.5 Veterinary Autogenous Vaccines Customers
13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
  • FORMAT: PDF
  • PUBLISHED DATE: Apr, 2021
  • NO OF PAGES: 130